Literature DB >> 17570000

Multidrug-resistant tuberculosis in the Czech Republic: strategy and therapeutic outcomes.

V Bartu1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17570000     DOI： 10.1007/s10096-007-0332-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  Fluoroquinolones in multidrug-resistant tuberculosis.

Authors:  Prasanta Raghab Mohapatra
Journal:  Am J Respir Crit Care Med       Date:  2004-10-15       Impact factor: 21.405

2.  Tuberculosis: a global problem at our doorstep.

Authors:  E Neil Schachter
Journal:  Chest       Date:  2004-12       Impact factor: 9.410

3.  Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

Authors:  M A Espinal; A Laszlo; L Simonsen; F Boulahbal; S J Kim; A Reniero; S Hoffner; H L Rieder; N Binkin; C Dye; R Williams; M C Raviglione
Journal:  N Engl J Med       Date:  2001-04-26       Impact factor: 91.245

4.  'Multidrug'-resistant tuberculosis. It is time to focus on the private sector of medicine.

Authors:  J A Sbarbaro
Journal:  Chest       Date:  1997-05       Impact factor: 9.410

Review 5.  Treatment of multidrug-resistant tuberculosis.

Authors:  M D Iseman
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

Review 6.  Management of multidrug-resistant tuberculosis and patients in retreatment.

Authors:  J A Caminero
Journal:  Eur Respir J       Date:  2005-05       Impact factor: 16.671

7.  Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns.

Authors:  Annelies van Rie; Thomas C Victor; Madalene Richardson; Rabia Johnson; Gian D van der Spuy; Emma J Murray; Nulda Beyers; Nico C Gey van Pittius; Paul D van Helden; Robin M Warren
Journal:  Am J Respir Crit Care Med       Date:  2005-06-09       Impact factor: 21.405

8.  Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.

Authors:  Carole Mitnick; Jaime Bayona; Eda Palacios; Sonya Shin; Jennifer Furin; Felix Alcántara; Epifanio Sánchez; Madeleny Sarria; Mercedes Becerra; Mary C Smith Fawzi; Saidi Kapiga; Donna Neuberg; James H Maguire; Jim Yong Kim; Paul Farmer
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.